clear cell carcinoma

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • (no location specified)
Sep 3, 2023

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (3 cycles chemo instead of 6 cycles chemo, 6 cycles

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • 3 cycles chemotherapy instead of 6 cycles chemotherapy
  • 6 cycles chemotherapy
  • (no location specified)
Jul 12, 2022

Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

Active, not recruiting
  • Uterine Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +7 more
Apr 4, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Germany (Rucaparib, Placebos)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Berlin, Germany
  • +22 more
Aug 30, 2021

Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)

Completed
  • Ewing Sarcoma
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 14, 2020

Endometrioid Adenocarcinoma, Serous Carcinoma, Clear Cell Carcinoma Trial in London (Image-guided adjuvant pelvic radiotherapy)

Recruiting
  • Endometrioid Adenocarcinoma
  • +4 more
  • Image-guided adjuvant pelvic radiotherapy
  • London, Ontario, Canada
    London Regional Cancer Program
Sep 2, 2020

Endometriosis and Frequency of Endometriosis-associated Ovarian

Withdrawn
  • Endometrioid Carcinoma
  • +2 more
    • (no location specified)
    Mar 31, 2015